1R3B

Solution structure of xenopus laevis Mob1

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D_13C-separated_NOESY	1mM Mob1 U-15N,13C	20mM Tris-HCl buffer; 500mM NaCl; 5mM DTT; 90% H2O, 10% D2O	500mM NaCl	8.0	ambient	300
2	3D_15N-separated_NOESY	1mM Mob1 U-15N,13C	20mM Tris-HCl buffer; 500mM NaCl; 5mM DTT; 90% H2O, 10% D2O	500mM NaCl	8.0	ambient	300
3	2D TOCSY	1mM Mob1 U-15N,13C	20mM Tris-HCl buffer; 500mM NaCl; 5mM DTT; 90% H2O, 10% D2O	500mM NaCl	8.0	ambient	300
4	HNCO	1mM Mob1 U-15N,13C	20mM Tris-HCl buffer; 500mM NaCl; 5mM DTT; 90% H2O, 10% D2O	500mM NaCl	8.0	ambient	300
5	HNCACB	1mM Mob1 U-15N,13C	20mM Tris-HCl buffer; 500mM NaCl; 5mM DTT; 90% H2O, 10% D2O	500mM NaCl	8.0	ambient	300
6	HNCOCA	1mM Mob1 U-15N,13C	20mM Tris-HCl buffer; 500mM NaCl; 5mM DTT; 90% H2O, 10% D2O	500mM NaCl	8.0	ambient	300
7	HNCA	1mM Mob1 U-15N,13C	20mM Tris-HCl buffer; 500mM NaCl; 5mM DTT; 90% H2O, 10% D2O	500mM NaCl	8.0	ambient	300
8	CBCACONH	1mM Mob1 U-15N,13C	20mM Tris-HCl buffer; 500mM NaCl; 5mM DTT; 90% H2O, 10% D2O	500mM NaCl	8.0	ambient	300
9	HNCACO	1mM Mob1 U-15N,13C	20mM Tris-HCl buffer; 500mM NaCl; 5mM DTT; 90% H2O, 10% D2O	500mM NaCl	8.0	ambient	300
10	3D HCCH-TOCSY	1mM Mob1 U-15N,13C	20mM Tris-HCl buffer; 500mM NaCl; 5mM DTT; 90% H2O, 10% D2O	500mM NaCl	8.0	ambient	300

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600
2	Varian	UNITY	800

NMR Refinement
Method	Details	Software
torsion angle dynamics	DYANA structures were energy minimized in CNS	Gifa

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Additional NMR Experimental Information
Details	The structure was determined using triple-resonance NMR spectroscopy.

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	Gifa	4.0	Delsuc
2	structure solution	DYANA	1.5	Guntert
3	refinement	CNS	1.0	Brunger

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.